Physician profile
David Zhang
NPI 1144857715
$8,767.85
in general payments reported to CMS, 2019-2025
19 companies · $8,555 in 2025
The $8,555 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $213 · 2025: $8,555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,321 · Food and Beverage: $4,160 · Education: $74.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,320.58 |
| Food and Beverage | $4,159.61 |
| Education | $74.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,434.59 | 2025 | Aurora Ev-Icd Mri Surescan, Cobalt Dr Mri Surescan, Micra |
| Abbott Laboratories | $2,143.42 | 2025 | Merlin@Home, Gallant, Jot Dx |
| Biosense Webster, INC. | $1,288.00 | 2025 | Carto 3 |
| Shockwave Medical, INC | $276.88 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $236.14 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $212.91 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $210.52 | 2025 | Wainua |
| Kestra Medical Technology Services, INC. | $146.81 | 2025 | Assure Wcd |
| Biotronik INC. | $141.10 | 2025 | Acticor 7 Vr-T Dx, Amvia Edge |
| E.R. Squibb & Sons, L.L.C. | $136.39 | 2025 | Camzyos |
| Actelion Pharmaceuticals US, INC. | $109.90 | 2025 | |
| Penumbra, INC. | $108.48 | 2025 | Indigo System, Penumbra System |
| Chiesi USA, INC. | $98.18 | 2025 | Cleviprex, Kengreal |
| Pfizer INC. | $81.64 | 2025 | |
| Abiomed | $58.18 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $29.16 | 2025 | Repatha |
| Terumo Medical Corporation | $25.65 | 2025 | Metacross Otw, Progreat, Glidewire |
| Idorsia Pharmaceuticals US INC | $15.88 | 2025 | Tryvio |
| Novo Nordisk INC | $14.02 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Zhang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.